Jo-Nan Liao
Overview
Explore the profile of Jo-Nan Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
211
Citations
1887
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao J, Chan Y, Kuo L, Tsai C, Liu C, Chen T, et al.
Eur Heart J Qual Care Clin Outcomes
. 2025 Jan;
PMID: 39844352
Objective: To analyze the temporal trends of oral anticoagulant (OAC) prescription, direct oral anticoagulant (DOAC) dose, clinical outcomes and factors associated with non-anticoagulation in patients with incident atrial fibrillation (AF)....
2.
Chen W, Liu C, Tseng C, Huang C, Wu I, Chen P, et al.
BMC Med Res Methodol
. 2024 Dec;
24(1):318.
PMID: 39716064
Background: Undetected atrial fibrillation (AF) poses a significant risk of stroke and cardiovascular mortality. However, diagnosing AF in real-time can be challenging as the arrhythmia is often not captured instantly....
3.
Kuo L, Chan Y, Liao J, Chen T, Lip G, Chen S, et al.
Heart Rhythm
. 2024 Nov;
PMID: 39613206
Background: Hematuria is common in patients with atrial fibrillation (AF) on oral anticoagulants (OACs). However, risks of incident genitourinary (GU) malignancy and detailed etiologies of hematuria have not been well...
4.
Liao J, Chan Y, Kuo L, Tsai C, Liu C, Chen T, et al.
Heart Rhythm
. 2024 Aug;
22(2):486-494.
PMID: 39094727
Background: The impact of post-stroke antithrombotic regimen in atrial fibrillation is uncertain. Objective: This study aimed to describe antithrombotic therapy prescribing patterns after ischemic stroke and the impact on outcomes....
5.
Cheng W, Chung F, Lin Y, Lo L, Chang S, Hu Y, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(9):324.
PMID: 39077706
Arrhythmogenic cardiomyopathy (ACM) is a group of arrhythmogenic disorders of the myocardium that are not caused by ischemic, hypertensive, or valvular heart disease. The clinical manifestations of ACMs may overlap...
6.
Liao J, Huang Y, Tsai C, Kuo L, Chen S, Tuan T, et al.
Rev Cardiovasc Med
. 2024 Jul;
25(3):92.
PMID: 39076938
Background: Gender is a well-recognized risk factor in atrial fibrillation (AF)-related ischemic stroke. The association of gender with the use of oral anticoagulants (OACs) and prognosis remains unknown. Methods: The...
7.
Chung F, Chao T, Lee A, Sung K, Huang W, Hsiao C, et al.
JACC Adv
. 2024 Jun;
2(9):100654.
PMID: 38938730
Background: Left ventricular (LV) systolic strain is presumably a more sensitive myocardial indicator than LV ejection fraction (LVEF). Data regarding the use of LV strain in clinical risk stratification and...
8.
Nguyen D, Lin C, Chung F, Chang T, Lo L, Lin Y, et al.
Front Cardiovasc Med
. 2024 May;
11:1306055.
PMID: 38689859
Introduction: Signal-averaged electrocardiography (SAECG) provides diagnostic and prognostic information regarding cardiac diseases. However, its value in other nonischemic cardiomyopathies (NICMs) remains unclear. This study aimed to investigate the role of...
9.
Tsai C, Chan Y, Liao J, Chen T, Lip G, Chen S, et al.
BMC Med
. 2024 Mar;
22(1):113.
PMID: 38475752
Background: In post-stroke atrial fibrillation (AF) patients who have indications for both oral anticoagulant (OAC) and antiplatelet agent (AP), e.g., those with carotid artery stenosis, there is debate over the...
10.
Tsai C, Liao J, Chan Y, Kuo L, Liu C, Lip G, et al.
Int J Cardiol Heart Vasc
. 2024 Feb;
50:101333.
PMID: 38419610
Introduction: Reduced-dose (Low-dose [LD]) apixaban is recommended in patients with atrial fibrillation (AF) who fulfill 2 of 3 criteria: age ≥ 80 years, body weight ≤ 60 kg, and a...